Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Advanced-Stage Prostate Cancer Patients
experience 20-Year Survival Rates with
Surgery
Newswise, May 17, 2011--Long-term survival
rates for patients with advanced prostate
cancer suggest they can be good candidates
for surgery, Mayo Clinic researchers have
found.
Their study found a 20-year survival rate
for 80 percent of patients diagnosed with
cancer that has potentially spread beyond
the prostate, known as cT3 prostate cancer,
and treated with radical prostatectomy, or
surgery to remove the prostate gland.
Previously, patients found to have cT3
prostate cancer were offered radiation or
hormone treatment, but not radical
prostatectomy.
The researchers presented their findings
during the American Urological Association
Annual Meeting in Washington.
“We are doing a much better job of
identifying and expanding candidates for
surgery, which results in better, longer
outcomes for so many of our patients,” says
R. Jeffrey Karnes, M.D., of Mayo Clinic’s
Department of Urology.
“We have confirmed that patients diagnosed
with locally advanced prostate cancer can
enjoy a long, cancer-free interval.”
The 80 percent survival rate for cT3
diagnoses at 20 years compares to 90 percent
for cT2, or cancer confined to the prostate.
This long-term follow-up of patients who
underwent surgery between 1987 and 1997 is
an important advance in understanding the
quality outcomes for cT3 patients.
The study sample included patients diagnosed
and operated on between 1987 and 1997.
Ongoing research will examine contemporary
data.
Other
study investigators include Christopher
Mitchell, M.D., Eric Umbreit, M.D., Rachel
Carlson and Laureano Rangel, all of Mayo
Clinic.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader
in medical care, research and education for
people from all walks of life. For more
information, visit www.mayoclinic.org/about/ and
www.mayoclinic.org/news.
... ..
...
...
